title: Comparison of efficacy between paclitaxel-eluting stents with different polymers in terms of major adverse cardiac events and stent thrombosis up to 12 months of clinical follow-up.
authors: Soon Yong
authors: SY
authors: Suh
authors: Kyoung Hoon
authors: KH
authors: Lee
authors: Jeonggeun
authors: J
authors: Moon
authors: Woong Chol
authors: WC
authors: Kang
authors: Seung Hwan
authors: SH
authors: Han
authors: Tae Hoon
authors: TH
authors: Ahn
authors: Eak Kyun
authors: EK
authors: Shin
mesh_terms: D000368:Aged; D002318:Cardiovascular Diseases / Q000139:chemically induced / Q000453:epidemiology*; D015331:Cohort Studies; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D017239:Paclitaxel / Q000008:administration & dosage* / Q000009:adverse effects; D011108:Polymers / Q000737:chemistry; D012189:Retrospective Studies; D013927:Thrombosis / Q000139:chemically induced / Q000453:epidemiology*; D016896:Treatment Outcome
chemical_list: D011108:Polymers; D017239:Paclitaxel